FORMULATION DESIGN AND IN VITRO EVALUATION OF BILAYER SUSTAINED RELEASE MATRIX TABLETS OF DOXOFYLLINE
Keywords:
Bilayer tablet, Sustained release, Doxofylline, Immediate release, HPMC, EudragitAbstract
Objective: To develop bilayer matrix tablet of Doxofylline by providing a loading dose followed by the maintenance dose that suppose to enhance the therapeutic efficacy the drug for acute and sustainable asthma.
Methods: Both immediate release layer and sustained release layer were prepared by wet granulation methods. Different Pre compression and post compression characterization of the tablet were carried out. Swelling studies were carried out for all the formulation. To optimise the immediate release layer, similarity (f2) and difference factor (f1) were calculated and optimised IR formulation was used for all formulations of bilayer tablet. In-vitro release studies were carried out in USP II paddle type dissolution apparatus for different formulations and release kinetic studies were carried out different kinetic model. FTIR and DSC studies were carried out for pure drug Doxofylline, IR layer and SR layer of optimised formulation to know the physical and chemical compatibility of drug and excipients. Accelerated stability studies were carried out to confirm the stability of dosage forms.
Results: Pre compression and post compression parameters satisfied with pharmacopeia specifications. The formulation that contained highest percent of HPMC had highest swelling index. Formulation DBMF6 showed an initial release of 44% of drug within one hour as the loading dose and remaining drug were sustained release up to 12 h. Release kinetic followed Hixon-Crowell kinetic model with drug release mechanism quasi-fickian diffusion. From accelerated stability studies no significant changes in physicochemical properties were noticed.
Conclusion: Doxofylline bilayer matrix tablets were successfully developed and can be used as an alternative to the conventional dosage form because it can be therapeutically beneficial for management of asthma.
Â
Downloads
References
Shiyani B. Formulation and evaluation of bilayer tablet of Metoclopramide hydrochloride and Ibuprofen. AAPS PharmSciTech 2008;9:818-27.
Bandari S. Formulation and evaluation of multiple tablets as a biphasic gastroretentive floating drug delivery system for Fenoverine. Acta Pharm 2010;60:89-97.
Jain NK. Controlled and novel drug delivery. 1st edn. CBS Publishers: New Delhi; 2004. p. 236-55.
Kumar AH, Kavitha K, Kumar SA, Kumar MR, Singh SDJ. Novel approach of bilayer tablet technology–a review. Int J Pharm Chem Biol Sci 2013;3:887-93.
Shukla D, Chakraborty S, Singh S, Mishra B. Doxofylline: a promising methylxanthine derivative for the treatment of asthma and chronic obstructive pulmonary disease. Expert Opin Pharmacother 2009;10:2343-56.
Prajapati PH, Nakum VV, Patel CN. Formulation and evaluation of floating matrix tablet of Stavudine. Int J Pharm Invest 2012;2:83-9.
Dey S, Mahanti B, Khila S, Mazumder B, Gupta SD. Formulation development and optimization of bilayer tablets of aceclofenac. Expert Opin Drug Delivery 2012;9:1041-50.
Patra CN, Kumar AB, Pandit HK, Singh SP, Devi MV. Design and evaluation of sustained release bilayer tablets of Propranolol hydrochloride. Acta Pharm 2007;57:479-89.
Narendra C, Srinath MS, Babu G. Optimization of bilayer floating tablet containing metoprolol tartrate as a model drug for gastric retention. AAPS PharmSciTech 2006;7:E34.
Majeed SM, Khali YI. Formulation and evaluation of bilayer matrix tablets of amoxicillin and esomeprazole as an oral modified release dosage form for treatment of peptic ulcer. Int J Pharm Pharm Sci 2014;6:134-42.
Panda N, Sultana A, Reddy AV, Reddy GVS, Ansari M S. Formulation design and study the effect of Polyplasdone-XL and AC-Di-Sol on release profile of doxofylline immediate release tablets. Int J Pharm Sci Rev Res 2015;32:67-76.
Malewar N, Avachat M, Pokharkar V, Kulkarni S. Controlled release of ropinirole hydrochloride from a multiple barrier layer tablet dosage form: effect of polymer type on pharmacokinetics and IVIVC. AAPS PharmSciTech 2013;14:1178-89.
Singh TP, Singh RK, Shah JN, Mehta TA. Mucoadhesive bilayer buccal patches of Verapamil hydrochloride: Formulation development and characterization. Int J Pharm Pharm Sci 2014;6:234-41.
Lopes CM. Compressed matrix core tablet as a quick/slow dual-component delivery system containing ibuprofen. AAPS PharmSciTech 2007;8:E195-02.
Akbar M, Panda N, Reddy AV. Formulation and evaluation of Doxofylline sublingual tablets using sodium starch glycolate and crosscarmellose sodium as superdisintegrant. Int J Pharm Res All Sci 2015;4:90-100.
Wei He, Yongji Li, Rao Zhang, Zhannan Wu, Lifang Yin. Gastro-floating bilayer tablets for the sustained release of metformin and immediate release of pioglitazone: Preparation and in vitro/in vivo evaluation. Int J Pharm 2014;476:223–31.
Darekar SS, Khadabadi SS, Shahi SR. Formulation and evaluation of bilayer buccal tablet of sumatriptan succinate. Int J Pharm Pharm Sci 2014;6:469-75.
P Sunny Gils. Controlled release of Doxofylline from biopolymer based Hydrogels. Am J Biomed Sci 2010;2:373-83.
Deepika KL, Kumar PS. Design, development and evaluation of Domperidone maleate bilayer tablets. Int J Pharm Pharm Sci 2013;5:701-10.
Ahmed. Formulation and in vitro evaluation of Diclofenac sodium sustained release matrix tablets using carnauba wax as a matrix former. Int J Pharm Pharm Sci 2014;6:461-6.
Islam MS, Reza S, Rahman H. In vitro release kinetics study of diltiazem hydrochloride from wax and kollidon sr based matrix tablets. Iranian J Pharm Res 2008;7:101-8.
Panda N, Panda KC, Reddy AV, Reddy GV. Process optimization, Formulation and evaluation of hydrogel {Guargum-G-Poly(Acrylamide)} based Doxofylline microbeads. Asian J Pharm Clin Res 2014;7:60-5.
Raju KN, Velmurugan S, Deepika B, Sundar V. Formulation and In vitro Evaluation of buccal tablets of metoprolol tartrate. Int J Pharm Pharm Sci 2011;3:239-46.
Ali MS, Pandit V, Jain M, Dhar KL. Mucoadhesive microparticulate drug delivery system of curcumin against Helicobacter pylori infection: Design, development and optimization. J Adv Pharm Tech Res 2014;5:48-56.